Canada Radiopharmaceuticals Market to 2032
Overview
The Canada Radiopharmaceuticals Market is expected to reach a 2,292.71 USD Billion by 2032 and is projected to grow at a CAGR of 10.31% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1,324.25
Forecast, 2032 (USD Billion)
2,292.71
CAGR, 2024 - 2032
10.31%
Report Coverage
Canada
Canada Radiopharmaceuticals Market 2018-2032 USD Billion
Canada Radiopharmaceuticals Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1,324.25 USD Billion
- Projected Market Size (2032): 2,292.71 USD Billion
- CAGR (2025-2032): 10.31%
Key Findings of Canada Radiopharmaceuticals Market
- The Canada Radiopharmaceuticals Market was valued at 2,292.71 USD Billion in 2024.
- The Canada Radiopharmaceuticals Market is likely to grow at a CAGR of 10.31% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Nuclear Reactors in By Source Segment accounted for the largest share of the market with a revenue of 762.40 USD Billion
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 11.20% during the forecast period from 2024 to 2032.
Canada Radiopharmaceuticals Market Scope
Canada Radiopharmaceuticals Market Segmentation & Scope
By Type
- Therapeutic Radiopharmaceuticals
- Diagnostic Radiopharmaceuticals
End User
- Others
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Diagnostic Centers
- Hospitals
By Application
- Therapeutic
- Diagnostic
By Source
- Cyclotrons
- Nuclear Reactors
Canada Radiopharmaceuticals Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1,324.25 USD Billion |
| Market Value in 2032 | 2,292.71 USD Billion |
| CAGR (2025-2032) | 10.31% |
| Historic Data | 2016-2023 |
| Market Segments Covered | By Type,End User,By Application,By Source |
Regional Insights:
-
Leading Market (2024-2032): Canada, leading in terms of revenue 1,324.25 USD Billion in 2024
- Key Country: Canada, leading in terms of revenue with value of 1,324.25 USD Billion in 2024.
Segments and Scope
-
Canada Radiopharmaceuticals Market to 2032, By By Type
- Diagnostic Radiopharmaceuticals is the largest segment in Canada Radiopharmaceuticals Market to 2032 with a revenue of 717.70 USD Billion in the year 2024.
- Diagnostic Radiopharmaceuticals is the Fastest growing segment in Canada Radiopharmaceuticals Market to 2032 with a Growth rate of 10.90 % in forecast period 2025-2032.
-
Canada Radiopharmaceuticals Market to 2032, By End User
- Hospitals is the largest segment in Canada Radiopharmaceuticals Market to 2032 with a revenue of 464.41 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Canada Radiopharmaceuticals Market to 2032 with a Growth rate of 11.20 % in forecast period 2025-2032.
-
Canada Radiopharmaceuticals Market to 2032, By By Application
- Diagnostic is the largest segment in Canada Radiopharmaceuticals Market to 2032 with a revenue of 686.52 USD Billion in the year 2024.
- Diagnostic is the Fastest growing segment in Canada Radiopharmaceuticals Market to 2032 with a Growth rate of 10.92 % in forecast period 2025-2032.
-
Canada Radiopharmaceuticals Market to 2032, By By Source
- Nuclear Reactors is the largest segment in Canada Radiopharmaceuticals Market to 2032 with a revenue of 762.40 USD Billion in the year 2024.
- Nuclear Reactors is the Fastest growing segment in Canada Radiopharmaceuticals Market to 2032 with a Growth rate of 10.80 % in forecast period 2025-2032.
Canada Radiopharmaceuticals Market Company Share Analysis
| Company Name |
|
||
| Cardinal Health | |||
| Advanced Accelerator Applications, A Novartis Company | |||
| GE HealthCare | |||
| Lantheus | |||
| Curium and its affiliates | |||
Canada Radiopharmaceuticals Market Geographical Sales Distribution, 2018-2032 USD Billion
Canada Radiopharmaceuticals Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Canada Radiopharmaceuticals Market is segmented based on Segmentation By Type,End User,By Application,By Source.
Canada Radiopharmaceuticals Market was valued at USD 1,324.25(Revenue in USD Billion) in 2021.
Canada Radiopharmaceuticals Market is projected to grow at a CAGR of 10.31% during the forecast period of 2024 to 2032.
The Nuclear Reactors segment is expected to dominate the Canada Radiopharmaceuticals Market, holding a largest market share of 762.40 USD Billion in 2024
Canada Radiopharmaceuticals Market Scope
Canada Radiopharmaceuticals Market Segmentation & Scope
By Type
- Therapeutic Radiopharmaceuticals
- Diagnostic Radiopharmaceuticals
End User
- Others
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Diagnostic Centers
- Hospitals
By Application
- Therapeutic
- Diagnostic
By Source
- Cyclotrons
- Nuclear Reactors
Frequently Asked Questions
The Canada Radiopharmaceuticals Market is segmented based on Segmentation By Type,End User,By Application,By Source.
Canada Radiopharmaceuticals Market was valued at USD 1,324.25(Revenue in USD Billion) in 2021.
Canada Radiopharmaceuticals Market is projected to grow at a CAGR of 10.31% during the forecast period of 2024 to 2032.
The estimated market value of the Canada Radiopharmaceuticals Market for final year is USD 2,292.71 (USD Billion).
Canada Radiopharmaceuticals Market Company Profiling
Frequently Asked Questions
The Canada Radiopharmaceuticals Market is segmented based on Segmentation By Type,End User,By Application,By Source.
Canada Radiopharmaceuticals Market was valued at USD 1,324.25(Revenue in USD Billion) in 2021.
Canada Radiopharmaceuticals Market is projected to grow at a CAGR of 10.31% during the forecast period of 2024 to 2032.
The estimated market value of the Canada Radiopharmaceuticals Market for final year is USD 2,292.71 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.